Clinical trial design for immunomodulatory biologics.
Essayan
D M
DM
Division of Clinical Trial Design and Analysis, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20852-1448, USA.
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D012107:Research Design
D000276:Adjuvants, Immunologic